Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist - Concepedia

Concepedia

Publication | Open Access

Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist

DOI Full Paper Access

29

Citations

21

References

2011

Year

Changsheng Zheng, Ganfeng Cao, Michael Xia, Hao Feng, Joseph Glenn, Rajan Anand, Ke Zhang, Taisheng Huang, Anlai Wang, Ling Kong,

Bioorganic & Medicinal Chemistry Letters

MedicineImmunologyPharmacological AgentCcr5 AntagonistPharmacotherapyDrug DevelopmentPharmacologyNovel TherapyBioavailable Dual Ccr2Drug Discovery

References

	Year	Citations

Page 1

Page 1